Clinical Trials Directory

Trials / Conditions / Hemorrhagic Disorders

Hemorrhagic Disorders

14 registered clinical trials studyying Hemorrhagic Disorders — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingBleeding Disorder of Unknown Cause in the Netherlands
NCT07454161
Maastricht University Medical Center—
Not Yet RecruitingComparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time in Situatio
NCT06974396
University Hospital, Strasbourg, FrancePhase 4
RecruitingComparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factori
NCT06705829
University Hospital, Strasbourg, France—
RecruitingA Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
NCT06271252
OriCell Therapeutics Co., Ltd.Phase 1
WithdrawnThe Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune
NCT06291415
HutchmedPhase 1
UnknownAssesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
NCT05654766
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus—
UnknownNatural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
NCT04309084
Celularity IncorporatedPhase 1
CompletedDose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals
NCT03734588
Spark Therapeutics, Inc.Phase 1 / Phase 2
CompletedLead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy
NCT03876301
Spark Therapeutics, Inc.—
CompletedDetermination of Fibrin Activity in Plasma on STA-R® Prototype
NCT02856789
Diagnostica Stago R&D—
CompletedComparison of Accidents and Their Circumstances With Oral Anticoagulants
NCT02376777
CNGE IRMG Association—
CompletedA Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
NCT01787552
Novartis PharmaceuticalsPhase 1 / Phase 2
CompletedStandardisation of Investigations of Mild Bleeding Disorders
NCT02329899
University Hospital, Geneva—
CompletedCooperative Study of Factor VIII Inhibitors
NCT00000582
National Heart, Lung, and Blood Institute (NHLBI)Phase 3